PMID: 6160535Jul 1, 1980Paper

Three-year clinical experience with a new endocardial screw-in lead with introduction protection for use in the atrium and ventricle

Pacing and Clinical Electrophysiology : PACE
H J BispingH Birkenheier

Abstract

There is still a high incidence of dislodgement, threshold rises, and loss of sensing with permanent transvenous endocardial leads. Atrial leads are an even greater problem and require particularly reliable methods of fixation. In March, 1976 we reported our preliminary results from animal experiments using a new transvenous screw-in lead with introduction protection. This lead differs from other screw-in models as its spiral tip is retracted in the insulating tube during insertion. For fixation purposes a torque is applied to the proximal end of the conductor coil, which is loosely positioned within the tube, and this moves the helical electrode forward. One hundred and fifty endocardial electrodes have been implanted; 127 of them in the dilated ventricle and 23 in the atrium. The technique of introducing the lead into the vein (cephalic or jugular) was the same as that for conventional leads. It was easy to manage and quite uncomplicated. The fixation features in the atrium or the ventricle were sufficiently reliable to allow some patients to go home several hours post-implant. The total working time of the leads used has been 900 months; the overall complication rate is 2%.

References

Jan 1, 1978·Pacing and Clinical Electrophysiology : PACE·N P Smyth
Jan 1, 1979·Biomedizinische Technik. Biomedical Engineering·H J Bisping

❮ Previous
Next ❯

Citations

Jan 1, 1983·Journal of the American College of Cardiology·V Parsonnet, A D Bernstein
Jul 1, 1982·Archives of Disease in Childhood·D E WardE A Shinebourne
Aug 1, 1981·British Heart Journal·E J PerrinsB Terpstra
Aug 1, 1983·British Heart Journal·E J PerrinsR Sutton
Mar 1, 1988·Mayo Clinic Proceedings·P H Belott
Dec 29, 2000·Mayo Clinic Proceedings·M GliksonM Eldar
Mar 21, 2007·Pacing and Clinical Electrophysiology : PACE·David M LuriaMichael Glikson
Jan 1, 1990·IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society·K Stokes
Apr 15, 1990·The American Journal of Cardiology·M de BuitleirF Morady
Jun 1, 1985·International Journal of Cardiology·J EnnkerH Oelert
Nov 1, 1987·International Journal of Cardiology·P H Belott
Nov 1, 1988·Clinical Cardiology·A S ManolisS J Baptist
Mar 10, 2000·Cardiology Clinics·G H Crossley
Nov 1, 1991·Journal of Veterinary Internal Medicine·D SissonL A DeLellis
Jan 1, 1991·Pacing and Clinical Electrophysiology : PACE·E S BarinA W Nathan
May 1, 1986·Pacing and Clinical Electrophysiology : PACE·A J GreensponR M Greenberg
May 1, 1991·Pacing and Clinical Electrophysiology : PACE·P Stirbys
Jan 1, 1994·Pacing and Clinical Electrophysiology : PACE·T O GreeneS K Huang
Sep 1, 1981·Pacing and Clinical Electrophysiology : PACE·H Mond
Jan 1, 1982·Pacing and Clinical Electrophysiology : PACE·T M BashoreG S Wagner
Sep 1, 1982·Pacing and Clinical Electrophysiology : PACE·R A NishimuraJ Merideth
Sep 1, 1982·Pacing and Clinical Electrophysiology : PACE·R A BillhardtR G Hauser
Nov 1, 1988·Pacing and Clinical Electrophysiology : PACE·D OrmerodR Heil
Aug 1, 1994·Pacing and Clinical Electrophysiology : PACE·M GliksonD L Hayes
Mar 1, 1983·Pacing and Clinical Electrophysiology : PACE·D MorseG M Lemole
Jul 1, 1983·Pacing and Clinical Electrophysiology : PACE·H C HughesR R Brownlee
Mar 1, 1984·Pacing and Clinical Electrophysiology : PACE·D HengleinG Burns
Mar 1, 1985·Pacing and Clinical Electrophysiology : PACE·S StarkM C Donaldson
Jun 3, 1999·Pacing and Clinical Electrophysiology : PACE·M GliksonD L Hayes
Sep 24, 2005·Pacing and Clinical Electrophysiology : PACE·David LuriaMichael Glikson
Jul 1, 1983·Pacing and Clinical Electrophysiology : PACE·K D DawkinsD E Ward
Mar 1, 1982·Pacing and Clinical Electrophysiology : PACE·D N Salem, J M Isner
Jan 1, 1983·Pacing and Clinical Electrophysiology : PACE·D BognoloD Jeffrey
Nov 1, 1994·Pacing and Clinical Electrophysiology : PACE·G H CrossleyJ A Brinker
Sep 1, 1995·Pacing and Clinical Electrophysiology : PACE·H G MondC C Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pacing and Clinical Electrophysiology : PACE
S FurmanI Campo
Pacing and Clinical Electrophysiology : PACE
S FurmanI Campo
Pacing and Clinical Electrophysiology : PACE
M Kleinert
© 2021 Meta ULC. All rights reserved